For example, biomarkers such as hyperphosphorylated tau protein (p-tau) and amyloid-beta (Aβ) can identify neuropathology associated with neurodegenerative diseases such as Alzheimer’s Disease (AD), prior to any cognitive decline. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.